Literature DB >> 2256898

The role of anxiety and depression in the irritable bowel syndrome.

E B Blanchard1, L Scharff, S P Schwarz, J M Suls, D H Barlow.   

Abstract

Using a reliable and valid structured diagnostic interview scale (ADIS-R), and patients with careful medical characterization, we found significantly more diagnosable psychopathology, particularly anxiety disorders, among treatment seeking patients with irritable bowel syndrome than among comparable age and sex samples of treatment seeking patients with Inflammatory Bowel Disease. Significant differences were also found on the Hamilton Anxiety Rating Scale and Hamilton Rating Scale for Depression between IBS patients and the IBD patients and controls, who did not differ. Comparable levels of psychiatric disorder among parents of probands were found in all three groups. The results are consistent with Latimer's (1983) notion of IBS patients being a subclass of 'neurotics'.

Entities:  

Mesh:

Year:  1990        PMID: 2256898     DOI: 10.1016/0005-7967(90)90159-g

Source DB:  PubMed          Journal:  Behav Res Ther        ISSN: 0005-7967


  22 in total

1.  Projections from bed nuclei of the stria terminalis, magnocellular nucleus: implications for cerebral hemisphere regulation of micturition, defecation, and penile erection.

Authors:  Hong-Wei Dong; Larry W Swanson
Journal:  J Comp Neurol       Date:  2006-01-01       Impact factor: 3.215

2.  Actual stress, psychopathology and salivary cortisol levels in the irritable bowel syndrome (IBS).

Authors:  F R Patacchioli; L Angelucci; G Dellerba; P Monnazzi; O Leri
Journal:  J Endocrinol Invest       Date:  2001-03       Impact factor: 4.256

3.  Psychologic Therapies for Irritable Bowel Syndrome.

Authors:  Philip Boyce
Journal:  Curr Treat Options Gastroenterol       Date:  2001-08

4.  Perceptions of illness stigma in patients with inflammatory bowel disease and irritable bowel syndrome.

Authors:  Tiffany H Taft; Laurie Keefer; Caroline Artz; Jason Bratten; Michael P Jones
Journal:  Qual Life Res       Date:  2011-03-20       Impact factor: 4.147

5.  Cognitive control network function in alcohol use disorder before and during treatment with lorazepam.

Authors:  Claire E Wilcox; Andrew R Mayer; Michael P Bogenschutz; Josef Ling; Charlene Dekonenko; Heather Cumbo
Journal:  Subst Use Misuse       Date:  2014-10-07       Impact factor: 2.164

6.  Intestinal transit in anxiety and depression.

Authors:  D A Gorard; J E Gomborone; G W Libby; M J Farthing
Journal:  Gut       Date:  1996-10       Impact factor: 23.059

7.  Irritable bowel syndrome and dyspepsia among women veterans: prevalence and association with psychological distress.

Authors:  L S Savas; D L White; M Wieman; K Daci; S Fitzgerald; S Laday Smith; G Tan; D P Graham; J A Cully; H B El-Serag
Journal:  Aliment Pharmacol Ther       Date:  2008-09-09       Impact factor: 8.171

8.  L-Lysine acts like a partial serotonin receptor 4 antagonist and inhibits serotonin-mediated intestinal pathologies and anxiety in rats.

Authors:  Miro Smriga; Kunio Torii
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-15       Impact factor: 11.205

9.  Migrating motor complex and sleep in health and irritable bowel syndrome.

Authors:  D A Gorard; C K Vesselinova-Jenkins; G W Libby; M J Farthing
Journal:  Dig Dis Sci       Date:  1995-11       Impact factor: 3.199

10.  Psychopathology in irritable bowel syndrome: support for a psychophysiological model.

Authors:  Mark A Sykes; Edward B Blanchard; Jeffery Lackner; Laurie Keefer; Susan Krasner
Journal:  J Behav Med       Date:  2003-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.